The aptamers market is growing rapidly due to the increasing demand for customized therapeutics and diagnostics tools in therapeutics development and diagnostics applications. Aptamers are short, single-stranded DNA or RNA oligonucleotides that bind to a specific target molecule. They can recognize molecules as small as ions and as large as proteins with high affinity and specificity. Aptamers are considered as an excellent alternative to antibodies due to their high specificity and affinity to target molecules, easy modification ability, non-immunogenicity, and long shelf life.
The global aptamers market is estimated to be valued at US$ 7217.85 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the aptamers market are ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, SCHILLER Americas Inc. Aptamers are gaining immense popularity as targeted therapeutics and diagnostic agents due to their high specificity and affinity to target molecules leading to growing demand in therapeutics and diagnostics applications. The growing R&D investment in developing economies and increasing collaborations between research institutes and market players are fueling the global expansion of the aptamers market.
The aptamers market is witnessing high growth owing to increasing R&D activities in therapeutics development. Aptamers are considered as a promising alternative to antibodies in therapeutics due to their non-immunogenic nature and high target specificity. Continuous advancement in SELEX technology is helping in rapid selection of aptamers against various targets enabling their use in targeted drug delivery and molecular diagnostics.
The growing application of aptamers in in-vitro diagnostics and biosensors is expected to drive the global market during the forecast period. Aptamers are increasingly replacing antibodies in diagnostics applications because of their high affinity, specificity for target molecules, long shelf life, and cost-effectiveness. Continuous technological advancement in SELEX and development of 3D printing technologies is further supporting the development of point-of-care testing using aptamers.
Market key trends:
One of the key trends gaining traction in the Aptamers Market Demand is their increasing adoption in theranostics. Theranostics involves combining therapeutic and diagnostic capabilities into single agents for personalized treatment of diseases. Aptamers can serve as ideal theranostic agents owing to their ability to specifically recognize disease targets and facilitate targeted drug delivery. This enables simultaneous detection, targeting, and treatment monitoring all through a single aptamer entity.
Porter’s Analysis
Threat of new entrants: The market has a high barrier for entry as it requires heavy investment and research capabilities.
Bargaining power of buyers: The market has moderate bargaining power of buyers as there are many players in the market with differentiated products.
Bargaining power of suppliers: The suppliers have low bargaining power as there are many suppliers in the market supplying raw materials required for production.
Threat of new substitutes: There is a low threat from substitutes as aptamers have unique features of targeted binding compared to any other molecular recognition elements.
Competitive rivalry: The rivalry is high as the key players compete on the basis of technology innovation, quality, and pricing.
Geographical Regions
North America has the largest share in the aptamers market in terms of value owing to increasing R&D investments and growing applications of aptamers therapeutics and diagnostics. The United States contributed the major share to North America aptamers market.
The Asia Pacific region is expected to witness the fastest growth in the aptamers market during the forecast period owing to rising investments for development of healthcare infrastructure, large population base and increasing prevalence of chronic diseases in the region. Countries such as China and India are expected to offer lucrative opportunities for players operating in the aptamers market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.